William P. Quinn

Business address
Sunesis Pharmaceuticals, Inc., 395 Oyster Point Boulevard, Suite 400, South San Francisco, CA, 94080
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
William P. Quinn has filed 19 SEC EDGAR filings since 12/4/2017

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 Oct 24, 2025 Oct 24, 2025 001-39988
4 Open Document Open Filing 4 May 5, 2025 May 1, 2025 001-39988
4 Open Document Open Filing 4 Jul 24, 2024 Jul 23, 2024 001-39988
4 Open Document Open Filing 4 Mar 6, 2024 Mar 4, 2024 001-39988
4 Open Document Open Filing FORM 4 SUBMISSION Dec 13, 2023 Dec 12, 2023 001-39988
4 Open Document Open Filing FORM 4 SUBMISSION Feb 28, 2023 Feb 27, 2023 001-39988
5 Open Document Open Filing FORM 5 SUBMISSION Feb 7, 2023 Dec 31, 2022 001-39988
4 Open Document Open Filing FORM 4 SUBMISSION Feb 23, 2022 Feb 18, 2022 001-39988
4 Open Document Open Filing FORM 4 SUBMISSION Dec 9, 2021 Dec 8, 2021 001-39988
4 Open Document Open Filing FORM 4 SUBMISSION Feb 9, 2021 Feb 9, 2021 001-39988
4 Open Document Open Filing FORM 4 SUBMISSION Feb 8, 2021 Feb 4, 2021 001-39988
3 Open Document Open Filing FORM 3 SUBMISSION Feb 4, 2021 Feb 4, 2021 001-39988
4 Open Document Open Filing FORM 4 SUBMISSION Apr 2, 2020 Mar 31, 2020 000-51531
4 Open Document Open Filing FORM 4 SUBMISSION Apr 1, 2019 Mar 29, 2019 000-51531
4 Open Document Open Filing FORM 4 SUBMISSION Mar 4, 2019 Feb 28, 2019 000-51531
4 Open Document Open Filing FORM 4 - Jan 3, 2019 Dec 31, 2018 000-51531
4 Open Document Open Filing FORM 4 - Dec 12, 2018 Dec 10, 2018 000-51531
4 Open Document Open Filing FORM 4 - Dec 4, 2017 Nov 30, 2017 000-51531
3 Open Document Open Filing FORM 3 - Dec 4, 2017 Nov 30, 2017 000-51531